A gold standard to improve cancer genome analysis
12/10/2015
Oncologists are increasingly using information obtained from investigations of the tumor genome in order to find individualized therapies for patients.
Melanoma treatment could benefit from nanotech drug delivery
12/10/2015
Researchers have developed nanoparticles that deliver three drugs that could improve treatment for metastatic melanoma and other cancers that spread through the lymphatic system.
How bad does it hurt? New research helps children suffering from chronic pain conditions
12/10/2015
A new study describes the development of pediatric pain measures for a National Institutes of Health Initiative aimed at helping doctors better evaluate and therefore better treat children who cope...
Bone cancer researchers discover how to block, potentially treat osteosarcoma
12/10/2015
Scientists at Princess Margaret Cancer Centre have discovered that blocking the master regulator of bone renewal stops osteosarcoma - the most common primary bone cancer in children and teens, and...
'Hijacking' and hibernating parasite could alter brain behavior
12/10/2015
Melbourne researchers have discovered how a common parasite hijacks host cells and stockpiles food so it can lie dormant for decades, possibly changing its host's behaviour or personality in the...
Imaging test detects aggressive and treatment-resistant cancers
12/10/2015
Scientists have developed a new imaging test that could enable doctors to identify more dangerous tumours before they spread around the body - and tailor treatment accordingly.
Drugs prevent heart damage during breast cancer treatment, study shows
12/10/2015
Heart medication taken in combination with chemotherapy reduces the risk of serious cardiovascular damage in patients with early-stage breast cancer, according to results from a new landmark clinical...
Capecitabine improved outcomes for breast cancer patients with disease after presurgery chemo
12/10/2015
Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results...
Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy
12/10/2015
Patients with other subtypes had benefit.Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or...
Denosumab improves disease-free survival for postmenopausal patients w HR+ breast cancer
12/10/2015
Previous results from ABCSG-18 showed denosumab also reduces clinical fractures.